NHS National Generics Pharmaceuticals - Supply Chain Resilience
- NHS England
Procurement identifier (OCID): ocds-h6vhtk-060abf
Description
NHS National Generics Pharmaceuticals - Supply Chain Resilience
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.
Periods of call-offs under the framework agreement:
CM/PHG/25/5739/01 - Orals (plus non-parenteral) Products
CESW: (Midlands and Southwest): 1st September 2026 to 31st May 2028 (21 months)
NWLN: (Northwest and London North): 1st September 2026 to 31st May 2028 (21 months)
LSNE: (London South and Northeast): 1st September 2026 to 31st May 2028 (21 months)
CM/PHG/25/5739/02 - Hospital Only Products
DLS (London South) & DNE (North-East): 1st September 2026 to 31st May 2028 (21 months)
DLN (London North) & DNW (North-West): 1st September 2026 to 31st May 2028 (21 months)
DCE (Central/Midlands) & DSW (South-West): 1st September 2026 to 30th September 2027 (13 months)
This tender is for lines that have recently been terminated or unable to be awarded on previous tenders. Please note we have previously referred to these as "Housekeeping" tenders.
Notices
UK4: Tender notice
- Notice identifier
- 2026/S 000-008379
- Published
- 30 January 2026, 11:36am
30 January 2026, 11:36am (latest version)
- 30 January 2026, 10:15am
UK2: Preliminary market engagement notice
- Notice identifier
- 2026/S 000-005168
- Published
- 21 January 2026, 10:56am